469
Views
0
CrossRef citations to date
0
Altmetric
Epidemiology

The incidence and prevalence of motor neurone disease in South Australia

ORCID Icon, ORCID Icon &
Pages 195-202 | Received 06 Apr 2022, Accepted 26 Jul 2022, Published online: 08 Aug 2022

References

  • Morris J. Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases: an overview. Neurodiagn J. 2015;55:180–94.
  • Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
  • Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Marin B, Boumediene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
  • Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
  • Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9:617–28.
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
  • Deloitte Access Economics. Economic analysis of motor neurone disease in Australia. Report for Motor Neurone Disease Australia. Canberra, Australia: Deloitte Access Economics; 2015.
  • Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771–6.
  • Australian Bureau of Statistics. Census of population and housing. Canberra, Australia: Australian government; 2016.
  • Government-of-South-Australia. Chief Public Health Officer’s report – data compendium, demographics. South Australia: Government of South Australia; 2016–2018.
  • Yoshida S, Uebayashi Y, Kihira T, Kohmoto J, Wakayama I, Taguchi S, et al. Epidemiology of motor neuron disease in the Kii Peninsula of Japan, 1989–1993: active or disappearing focus? J Neurol Sci. 1998;155:146–55.
  • Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13:1108–13.
  • United Nations. Department of Economic and Social Affairs, Population Division. World Population Prospects 2019: Data Booklet. ST/ESA/SER. A/424. 2019.
  • Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267:944–53.
  • Traynor B, Codd M, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology. 1999;52:504–9.
  • 2008. Department of Health Western Australia, ‘Motor Neurone Disease Services for Western Australia’, Motor Neurone Disease Project Group, Neurosciences & the Senses Health Network. 2008.
  • Rosenbohm A, Peter RS, Erhardt S, Lule D, Rothenbacher D, Ludolph AC, et al. Epidemiology of amyotrophic lateral sclerosis in Southern Germany. J Neurol. 2017;264:749–57.
  • Drigo D, Verriello L, Clagnan E, Eleopra R, Pizzolato G, Bratina A, et al. The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study. Neuroepidemiology. 2013;41:54–61.
  • McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557–70.
  • Westeneng H-J, Debray TP, Visser AE, van Eijk RP, Rooney JP, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423–33.
  • Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R, et al. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72:725–31.
  • Preux P-M, Druet-Cabanac M, Couratier P, Debrock C, Truong T, Marcharia W, et al. Estimation of the amyotrophic lateral sclerosis incidence by capture-recapture method in the Limousin region of France. J Clin Epidemiol. 2000;53:1025–9.
  • Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225–38.
  • Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:623–7.
  • Rooney JP, Brayne C, Tobin K, Logroscino G, Glymour MM, Hardiman O. Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease. Neurology. 2017;88:2321–9.
  • Hardiman O, Al-Chalabi A, Brayne C, Beghi E, van den Berg LH, Chio A, et al. The changing picture of amyotrophic lateral sclerosis: lessons from European registers. J Neurol Neurosurg Psychiatry. 2017;88:557–63.
  • Factor-Litvak P, Al-Chalabi A, Ascherio A, Bradley W, Chío A, Garruto R, et al. Current pathways for epidemiological research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:33–43.
  • Australian-Government. Maps of Australia: Geoscience Australia. 2022. Available at: https://www.ga.gov.au/data-pubs/maps.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.